HU Charles 胡正忠

Dr. Charles Hu

  • Founder & CEO, Ryoden Medical Holdings Ltd
  • Co-founder & Chief Medical Affairs Officer, Incando Therapeutics Ltd
  • Founding Partner, Cere Ventures Ltd
  • Johns Hopkins University, PhD in Tissue Engineering and Regenerative Medicine

Charles is a translational biomedical engineer with a strong background in business development. His passion is in bringing disruptive medical technologies to market. He co-founded Incando Therapeutics and heads Ryoden Medical where he oversees healthcare venture investments. He also advises angels, universities, and startups. He most recently established Cere Ventures — a syndicated group targeting and grooming brain- and aging-related developments for and into the GHKM Greater Bay Area. Charles is a board member of two biotechnology startups and director of several retail, F&B, and property businesses.